Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health

Kristina Roche, Brian Harnett, MD, Leona Browne, Stephanie Young, PharmD, Rufaro S. Chitsike, MD

Blood (2019) 134 (Supplement_1): 2447.

https://doi.org/10.1182/blood-2019-129340

Published: 2019

Journal Articles

Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

Guadalupe Belen Antelo, MD, Giacomo Coltro, MD, Abhishek A Mangaonkar, MBBS, Terra Lasho, PhD, Christy Finke, BS, Ryan M. Carr, MD PhD, Naseema Gangat, MBBS, Moritz Binder, MDMPH, Aref Al-Kali, MD, Michelle A Elliott, MD, Matthew T Howard, MD, Rebecca L. King, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Martin Fernandez-Zapico, MD, Mrinal M Patnaik, MDMBBS

Blood (2019) 134 (Supplement_1): 4182.

https://doi.org/10.1182/blood-2019-126199

Published: 2019

Journal Articles

An Unusual Case of Autoimmune Hemolytic Anemia-Thinking Outside the Box for Management

Paul C Williams, MD, Ileana Lopez-Plaza, MD

Blood (2018) 132 (Supplement 1): 5075.

https://doi.org/10.1182/blood-2018-99-111196

Published: 2018

Journal Articles

Splenomegaly in Adolescents and Adults with Sickle Cell Anemia in Tanzania Is Associated with Less Severe Disease

Neema Budodi Lubuva, MD MMed, Venee N. Tubman, MD MMSc, Clara C Chamba, MD MMed, Erius Tebuka, MD MMed, Mbonea Yonazi, MD MMed, Furahini Tluway, MD MPH, Pius Magesa, MD MPath, Lucio Luzzatto, MD, Julie Makani, MD PhD FRCP, Magdalena Lyimo, MD PhD

Blood (2017) 130 (Supplement 1): 4793.

https://doi.org/10.1182/blood.V130.Suppl_1.4793.4793

Published: 2017

Journal Articles

Splenic Infarct As an Harbinger for Sickle Cell Traits in High Altitude

Velu Nair, MBBS, MD, Uday Yanamandra, MBBS, Rajan Kapoor, MD DM, Rajiv Kumar, MBBS, MD DM, Satya Ranjan Das, MD, Ajay Sharma, MD, Singh Jasjit, MD, Suman Pramanik, MD, Sanjeevan Sharma, MD, Tarun Verma, MD

Blood (2017) 130 (Supplement 1): 4650.

https://doi.org/10.1182/blood.V130.Suppl_1.4650.4650

Published: 2017

Journal Articles

From a DOAC to Warfarin: Reasons Why Patients Switch

Aisling Barrett, MB, BCh, BAO, MRCPI, Sahar Khan, MRCPI, Margaret Moore, RGN, Patricia Ferrins, RGN, BSc, Jeremy Sargent, FRCPath, Patrick Thornton, Philip Murphy, John Quinn

Blood (2017) 130 (Supplement 1): 4910.

https://doi.org/10.1182/blood.V130.Suppl_1.4910.4910

Published: 2017

Journal Articles

Splenic Infarction Induced By Epstein-Barr Virus Infection in a Patient with Sickle Cell Trait

Rofida Nofal, MD, Hadi Sawaf, MD, Lida Zeinali, MD

Blood (2015) 126 (23): 4600.

https://doi.org/10.1182/blood.V126.23.4600.4600

Published: 2015

Journal Articles

Cost Effectiveness of Tyrosine Kinase Inhibitor (TKIs) Therapy in Chronic Myelogenous Leukemia (CML) in Comparison to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Based on the Nationwide Inpatient Sample (NIS) Database from 2002 to 2011

Indumathy Varadarajan, MD, Parshva Patel, MD, Ravindra Sangitha, BS, Kristine Ward, MD, Maneesh Jain, MD, Michael Styler, MD

Blood (2015) 126 (23): 4486.

https://doi.org/10.1182/blood.V126.23.4486.4486

Published: 2015

Journal Articles

Long Term Trends in Chronic Myeloid Leukemia (CML) Following the FDA Approval of Tyrosine Kinase Inhibitors (TKIs), on Bone Marrow Transplant Rates and Clinical Outcomes - a Study of the Nationwide Inpatient Sample Between 1998-2011

Parshva Patel, MD, Indumathy Varadarajan, MD, Gaurav Varma, MSPH, Trotta Christina, MD, Kristine Ward, MD, Maneesh Jain, MD, Michael Styler, MD

Blood (2015) 126 (23): 3300.

https://doi.org/10.1182/blood.V126.23.3300.3300

Published: 2015

Journal Articles

Investigation of Two Combination HbF Induction Regimens, RN-1 and Hydroxyurea Versus RN-1 and Decitabine, in a Humanized Sickle Cell Mouse Model

Ramasamy Jagadeeswaran, PhD, Yash Agarwal, Vinzon Ibanez, Maria Armila Ruiz, Kestis Vaitkus, Joseph DeSimone, PhD, Donald Lavelle, PhD, Angela Rivers, MD PhD

Blood (2015) 126 (23): 3386.

https://doi.org/10.1182/blood.V126.23.3386.3386

Published: 2015

Journal Articles

Complication Rates in Patients with Sickle Cell Disease Living Chronically at Moderate Altitude

Claire L Stokes, MD MPH, Christopher M McKinney, MD, Christopher C Silliman, MDPhD

Blood (2014) 124 (21): 4095.

https://doi.org/10.1182/blood.V124.21.4095.4095

Published: 2014

Journal Articles

A Phase II Study Of Tosedostat (TST) In Combination With Either Cytarabine Or Decitabine In Newly Diagnosed Older Patients With Acute Myeloid Leukemia (AML) Or High-Risk Myelodysplastic Syndrome (MDS)

Raya Mawad, MD, Pamela S. Becker, MD, PhD, Paul C. Hendrie, MD, PhD, Bart L Scott, MD, Brent L. Wood, MD, PhD, Carol Dean, RN, Ravinder K Sandhu, MD, H. Joachim Deeg, MD, Roland B. Walter, MD, PhD, Frederick R. Appelbaum, MD, Lixia Wang, PhD, Han Myint, MD, Jack Singer, MD, Elihu H. Estey, MD, John M. Pagel, MD, PhD

Blood (2013) 122 (21): 3926.

https://doi.org/10.1182/blood.V122.21.3926.3926

Published: 2013

Journal Articles

Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID

David T. Teachey, MD, TIffaney Vincent, Kim Smith-Whitley, MD, Michele P Lambert, MD, Alix E. Seif, MD, MPH, James T. Casper, MD, Stephan A Grupp, MD, PhD

Blood (2013) 122 (21): 330.

https://doi.org/10.1182/blood.V122.21.330.330

Published: 2013

Journal Articles

Splenic and Liver Involvement in Sickle Cell Disease

Giovanna Graziadei, MD, Alessia Marcon, MD, Ilaria Gandolfi, MD, Martina Soldarini, MD, Erika Poggiali, MD, Claudia Cesaretti, MD, Itala Marina Baldini, MD, Maria Domenica Cappellini, MD

Blood (2012) 120 (21): 4763.

https://doi.org/10.1182/blood.V120.21.4763.4763

Published: 2012

Journal Articles

Clinical Complications in Adult Patients with Sickle Cell Anemia and β-Thalassemia-Sickle Cell Disease

Giovanna Graziadei, MD, Alessia Marcon, MD, Martina Soldarini, MD, Ilaria Gandolfi, MD, Luisa Ronzoni, MD, PhD, Marianna Giuditta, MD, Pietro Ridolfi, Maria Domenica Cappellini, MD

Blood (2012) 120 (21): 4767.

https://doi.org/10.1182/blood.V120.21.4767.4767

Published: 2012

Journal Articles

Etiology and Management of Splenic Infarction and Splenic Vein Thrombosis: Unusual Causes of Abdominal Pain in Sickle Cell Trait Patient

Vladimir Gotlieb, Shuang Fu, Prajwol Pathak, Jeeny Job, Steve Walerstein, Boris Avezbakiyev

Blood (2012) 120 (21): 4775.

https://doi.org/10.1182/blood.V120.21.4775.4775

Published: 2012

Journal Articles

Recurrent Acute Splenic Sequestration in Two Children with Coinheritance of Sickle Cell Trait and Hereditary Spherocytosis.

Min Hee Kim, MD, Vishwas S Sakhalkar, MD, Dana Tunnell, MD, Carlos S. Alvarado, MD

Blood (2012) 120 (21): 2091.

https://doi.org/10.1182/blood.V120.21.2091.2091

Published: 2012

Journal Articles

Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis

Ayalew Tefferi, MD, Kebede Begna, MD, William J Hogan, MBBCh, Mark R. Litzow, MD, Curtis A Hanson, Animesh Pardanani, MBBS, PhD

Blood (2011) 118 (21): 1752.

https://doi.org/10.1182/blood.V118.21.1752.1752

Published: 2011

Journal Articles

Burden of Morbidities Associated with Splenomegaly and From Existing Treatments In Patients with Myelofibrosis

Claire N. Harrison, DM, Benjamin R. Elkins, MPH, Kimberly Yee, MPH, Dave Nellesen, PhD, Sonia Pulgar, MPH

Blood (2010) 116 (21): 5059.

https://doi.org/10.1182/blood.V116.21.5059.5059

Published: 2010

Journal Articles

Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial

Andre Goy, MD, Joseph Leach, MD, W. Christopher Ehmann, MD, Kiyoshi Ando, MD, PhD, Kiyohiko Hatake, MD, PhD, Kensei Tobinai, MD, PhD, Tatyana Feldman, MD, Steven Hua, Angela DG Volkert, Erik R. Vandendries, MD, PhD, Michinori Ogura, MD, PhD

Blood (2010) 116 (21): 430.

https://doi.org/10.1182/blood.V116.21.430.430

Published: 2010

NARROW

The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health

Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)

An Unusual Case of Autoimmune Hemolytic Anemia-Thinking Outside the Box for Management

Splenomegaly in Adolescents and Adults with Sickle Cell Anemia in Tanzania Is Associated with Less Severe Disease

Splenic Infarct As an Harbinger for Sickle Cell Traits in High Altitude

From a DOAC to Warfarin: Reasons Why Patients Switch

Splenic Infarction Induced By Epstein-Barr Virus Infection in a Patient with Sickle Cell Trait

Cost Effectiveness of Tyrosine Kinase Inhibitor (TKIs) Therapy in Chronic Myelogenous Leukemia (CML) in Comparison to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Based on the Nationwide Inpatient Sample (NIS) Database from 2002 to 2011

Long Term Trends in Chronic Myeloid Leukemia (CML) Following the FDA Approval of Tyrosine Kinase Inhibitors (TKIs), on Bone Marrow Transplant Rates and Clinical Outcomes - a Study of the Nationwide Inpatient Sample Between 1998-2011

Investigation of Two Combination HbF Induction Regimens, RN-1 and Hydroxyurea Versus RN-1 and Decitabine, in a Humanized Sickle Cell Mouse Model

Complication Rates in Patients with Sickle Cell Disease Living Chronically at Moderate Altitude

A Phase II Study Of Tosedostat (TST) In Combination With Either Cytarabine Or Decitabine In Newly Diagnosed Older Patients With Acute Myeloid Leukemia (AML) Or High-Risk Myelodysplastic Syndrome (MDS)

Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID

Splenic and Liver Involvement in Sickle Cell Disease

Clinical Complications in Adult Patients with Sickle Cell Anemia and β-Thalassemia-Sickle Cell Disease

Etiology and Management of Splenic Infarction and Splenic Vein Thrombosis: Unusual Causes of Abdominal Pain in Sickle Cell Trait Patient

Recurrent Acute Splenic Sequestration in Two Children with Coinheritance of Sickle Cell Trait and Hereditary Spherocytosis.

Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis

Burden of Morbidities Associated with Splenomegaly and From Existing Treatments In Patients with Myelofibrosis

Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only